GREENLAND MINES LTD Payments of Loan Costs
GREENLAND MINES LTD (GRML) reported Payments of Loan Costs of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfLoanCosts · last filed 2024-11-19
- GREENLAND MINES LTD payments of loan costs for the quarter ending 2024-09-30 was $0.00.
| Period end | Payments of Loan Costs 3 month | Payments of Loan Costs 6 month | Payments of Loan Costs 9 month | Payments of Loan Costs 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $0.00 10-Q · filed 2024-11-19 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-19 | |||
| 2023-12-31 | $0.00 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |